An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?

Título

An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?

Autor

Giuseppe Terrazzano, Angela Giovazzino, Valentina Rubino, Anna Teresa Palatucci, Giuseppina Ruggiero, Flavia Carriero

Fecha

2020

Materia

mTOR, Everolimus, immune regulation, hyper-activation, COVID-19

Identificador

DOI: 10.3389/fphar.2020.00856

Fuente

Frontiers in Pharmacology

Editor

Frontiers Media S.A.

Cobertura

Therapeutics. Pharmacology

Archivos

https://socictopen.socict.org/files/to_import/pdfs/5016447.pdf

Colección

Coronavirus

Citación

Giuseppe Terrazzano, Angela Giovazzino, Valentina Rubino, Anna Teresa Palatucci, Giuseppina Ruggiero, Flavia Carriero, “An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?,” SOCICT Open, consulta 27 de abril de 2026, https://socictopen.socict.org/items/show/3491.

Formatos de Salida

Position: 13170 (22 views)